Drug Design Laboratory, Graduate School of Medical Life Science, Yokohama City University, Tsurumi, Yokohama, 230-0045, Japan.
Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, 980-8578, Japan.
Nat Commun. 2023 Nov 6;14(1):7150. doi: 10.1038/s41467-023-42764-8.
Hydroxycarboxylic acid receptors (HCAR1, HCAR2, and HCAR3) transduce G signaling upon biding to molecules such as lactic acid, butyric acid and 3-hydroxyoctanoic acid, which are associated with lipolytic and atherogenic activity, and neuroinflammation. Although many reports have elucidated the function of HCAR2 and its potential as a therapeutic target for treating not only dyslipidemia but also neuroimmune disorders such as multiple sclerosis and Parkinson's disease, the structural basis of ligand recognition and ligand-induced G-coupling remains unclear. Here we report three cryo-EM structures of the human HCAR2-G signaling complex, each bound with different ligands: niacin, acipimox or GSK256073. All three agonists are held in a deep pocket lined by residues that are not conserved in HCAR1 and HCAR3. A distinct hairpin loop at the HCAR2 N-terminus and extra-cellular loop 2 (ECL2) completely enclose the ligand. These structures also reveal the agonist-induced conformational changes propagated to the G-protein-coupling interface during activation. Collectively, the structures presented here are expected to help in the design of ligands specific for HCAR2, leading to new drugs for the treatment of various diseases such as dyslipidemia and inflammation.
羟基羧酸受体 (HCAR1、HCAR2 和 HCAR3) 在与脂解和动脉粥样硬化活性以及神经炎症相关的分子(如乳酸、丁酸和 3-羟基辛酸)结合后,转导 G 信号。虽然许多报告已经阐明了 HCAR2 的功能及其作为治疗靶点的潜力,不仅可以治疗血脂异常,还可以治疗多发性硬化症和帕金森病等神经免疫疾病,但配体识别和配体诱导的 G 偶联的结构基础仍不清楚。在这里,我们报告了三种人源 HCAR2-G 信号复合物的冷冻电镜结构,每种都与不同的配体结合:烟酸、阿昔莫司或 GSK256073。所有三种激动剂都被一个由 HCAR1 和 HCAR3 中不保守的残基组成的深口袋固定。HCAR2 N 端的独特发夹环和细胞外环 2 (ECL2) 完全包围配体。这些结构还揭示了激动剂诱导的构象变化在激活过程中传播到 G 蛋白偶联界面。总的来说,这里呈现的结构有望帮助设计针对 HCAR2 的特异性配体,从而为治疗各种疾病(如血脂异常和炎症)提供新的药物。